Correlation between efficacy of levetiracetam and serum levels among children with refractory epilepsy

Pediatric Neurology

Volumn 52, Issue 6, 2015, Pages 624-628

  Sheinberg, Revital ^a   Heyman, Eli ^a,b   Dagan, Zahi ^a   Youngster, Ilan ^a   Kohn, Elkana ^a   Gandelman Marton, Revital ^a,b   Berkovitch, Matitiahu ^a,b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

children; concentrations; efficacy; Keppra; levetiracetam; refractory epilepsy; side effects

Indexed keywords

CLOBAZAM; ETIRACETAM; HARKOSERIDE; LAMOTRIGINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ANTICONVULSIVE AGENT; PIRACETAM;

ADOLESCENT; ADULT; ARTICLE; BEHAVIOR CHANGE; BENIGN CHILDHOOD EPILEPSY; CHILD; CLINICAL ARTICLE; DIZZINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MONITORING; DRUG RESISTANT EPILEPSY; DRUG TOLERABILITY; FATIGUE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; RESTLESSNESS; SEIZURE; ANALOGS AND DERIVATIVES; BLOOD; FACTUAL DATABASE; INFANT; PRESCHOOL CHILD; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DRUG RESISTANT EPILEPSY; FEMALE; HUMANS; INFANT; MALE; PIRACETAM; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84930379465     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2015.01.012     Document Type: Article

References (21)

1. B.A. Lynch, N. Lambeng, and K. Nocka The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam Proc Natl Acad Sci U S A 101 2004 9861 9866
2. P.N. Patsalos Pharmacokinetic profile of levetiracetam: toward ideal characteristics Pharmacol Ther 85 2000 77 85
3. J.M. Pellock, T.A. Glauser, and E.M. Bebin Pharmacokinetic study of levetiracetam in children Epilepsia 42 2001 1574 1579
4. P.C. Giroux, M. Salas-Prato, Y. Theoret, and L. Carmant Levetiracetam in children with refractory epilepsy: lack of correlation between plasma concentration and efficacy Seizure 18 2009 559 563
5. F. Lancelin, E. Franchon, and L. Kraoul Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy Ther Drug Monit 29 2007 576 583
6. T.A. Glauser, R. Ayala, and R.D. Elterman Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures Neurology 66 2006 1654 1660
7. J.E. Pina-Garza, D.R. Nordli Jr., D. Rating, H. Yang, J. Schiemann-Delgado, and B. Duncan Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures Epilepsia 50 2009 1141 1149
8. P.M. Levisohn, M. Mintz, S.J. Hunter, H. Yang, and J. Jones Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial Epilepsia 50 2009 2377 2389
9. M.J. Tan, and R.E. Appleton Efficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experience Seizure 13 2004 142 145
10. G. Coppola, E. Franzoni, and A. Verrotti Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial Brain Dev 29 2007 281 284
11. H. Kanemura, F. Sano, T. Tando, K. Sugita, and M. Aihara Efficacy and safety of add-on levetiracetam in refractory childhood epilepsy Brain Dev 35 2013 386 391
12. H. Goldberg-Stern, L. Feldman, and T. Eidlitz-Markus Levetiracetam in children, adolescents and young adults with intractable epilepsy: efficacy, tolerability and effect on electroencephalogram- A pilot study Eur J Paediatr Neurol 17 2013 248 253
13. S.H. Tonekaboni, M. Ghazavi, P. Karimzadeh, F. Mahvelati, and M. Ghofrani Efficacy of levetiracetam in children with refractory epilepsy as an add-on trial Epilepsy Res 90 2010 273 277
14. P.M. Callenbach, W.F. Arts, and R. ten Houten Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study Eur J Paediatr Neurol 12 2008 321 327
15. J. Opp, I. Tuxhorn, and T. May Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany Seizure 14 2005 476 484
16. T.W. May, B. Rambeck, and U. Jurgens Serum concentrations of Levetiracetam in epileptic patients: the influence of dose and co-medication Ther Drug Monit 25 2003 690 699
17. L. Lagae, G. Buyse, and B. Ceulemans Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial Seizure 14 2005 66 71
18. C. von Stuelpnagel, H. Holthausen, and G. Kluger Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy Eur J Paediatr Neurol 11 2007 341 345
19. D.S. Khurana, S.V. Kothare, I. Valencia, J.J. Melvin, and A. Legido Levetiracetam monotherapy in children with epilepsy Pediatr Neurol 36 2007 227 230
20. B. Abou-Khalil Benefit-risk assessment of levetiracetam in the treatment of partial seizures Drug Saf 28 2005 871 890
21. C. Helmstaedter, N.E. Fritz, E. Kockelmann, N. Kosanetzky, and C.E. Elger Positive and negative psychotropic effects of levetiracetam Epilepsy Behav 13 2008 535 541